Live Breaking News & Updates on Bluhm Family Professor

Stay updated with breaking news from Bluhm family professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023. ....

San Antonio , United States , Seemaa Khan , Feinberg School Of Medicine , Bluhm Family Professor Of Cancer Research , Cancer Research Group , Lurie Comprehensive Cancer Center , Cancer Research Network , Alliance For Clinical Trials In Oncology , Northwestern University , American Association For Cancer Research , San Antonio Breast Cancer Symposium , Bluhm Family Professor , Cancer Research , Feinberg School , Research Group , National Cancer Institute , National Institutes , Clinical Trials , Breast Cancer , Clinical Trial , Ductal Carcinoma ,

Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS

Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

San Antonio , United States , Seemaa Khan , Feinberg School Of Medicine , Bluhm Family Professor Of Cancer Research , Northwestern University , Lurie Comprehensive Cancer Center , Cancer Research Network , Cancer Research Group , Alliance For Clinical Trials In Oncology , San Antonio Breast Cancer Symposium , Bluhm Family Professor , Cancer Research , Feinberg School , Clinical Trials ,

Dr Khan on Optimizing Local Therapy Using MRI and a 12-Gene Expression Assay in DCIS

Seema A. Khan, MD, discusses 5-year clinical outcomes from the ECOG-ACRIN E4112 trial, which is evaluating the use of MRI and a 12-gene expression assay to optimize local therapy for patients with ductal carcinoma in situ. ....

Seemaa Khan , Northwestern University Feinberg School Of Medicine , Bluhm Family Professor Of Cancer Research , Optimizing Local Therapy Using , Gene Expression Assay , Partnership With , Bluhm Family Professor , Cancer Research , Northwestern University Feinberg School , Ecog Acrin E4112 Trial , Patients With Ductal Carcinoma In Situ ,

'Multiplicity of agents' saturate treatment landscape for de novo metastatic breast cancer

'Multiplicity of agents' saturate treatment landscape for de novo metastatic breast cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United States , Mindy Valcarcel , Byjennifer Southall , Seemaa Khan , Seema Khan , Northwestern Medicine Feinberg School Of , Bluhm Family Professor Of Cancer Research , National Comprehensive Cancer Network , Bluhm Family Professor , Cancer Research , Northwestern Medicine Feinberg School , North America ,

Envisagenics is Awarded Another SBIR Grant From the National Cancer Institute to Commercialize its AI/ML Platform for Immunotherapy Development

/PRNewswire/ Envisagenics, Inc., a New York-based biotechnology company leveraging artificial intelligence (AI) and RNA-splicing analytics for discovery and. ....

Bradley Harris , Martin Akerman , Maria Luisa Pineda , National Cancer Institute , Small Business Innovation Research , National Institutes Of Health , Cold Spring Harbor Laboratory , Northwestern University Feinberg School Of Medicine , Susan Clare Research Associate Professor Of Surgery , Bluhm Family Professor Of Cancer Research , Prnewswire Envisagenics Inc , Seema Khan Co , National Institute , New York Based , National Institutes , Chief Technology Officer , Northwestern University Feinberg School , Seema Khan , Cancer Prevention Program , Lurie Comprehensive Cancer Center , Bluhm Family Professor , Cancer Research , Susan Clare , Research Associate Professor , General Medical Sciences , Chief Executive Officer ,